Company intelligence / Profile preview

MPJ OTC

Stockholm, Sweden

Ownership: Private
Development stage: Other

Overview

In March 2019, Moberg Pharma completed the sale of its OTC-business (all shares in MPJ OTC AB and all units in Moberg Pharma North America LLC) for USD 155 million to RoundTable Healthcare Partners and Signet Healthcare Partners. The sold business covered global OTC brand operations, after which Moberg Pharma continued only with its clinical pharmaceutical assets[1][3][5].

Therapeutic areas: Dermatology
Industry: Biotech

Partnerships

RoundTable Healthcare PartnersSignet Healthcare Partners

Beyond the preview

Go deeper on MPJ OTC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MPJ OTC.

Explore the full profile